Krystal Biotech Ownership | Who Owns Krystal Biotech?


OverviewForecastRevenueFinancialsChartTranscripts

Krystal Biotech Ownership Summary


Krystal Biotech is owned by 95.56% institutional investors, 11.86% insiders. Fmr is the largest institutional shareholder, holding 15.02% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.42% of its assets in Krystal Biotech shares.

KRYS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKrystal Biotech95.56%11.86%-7.42%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr4.31M15.02%$675.83M
Blackrock3.95M13.95%$724.98M
Blackrock funding, inc. /de3.85M13.30%$528.56M
Vanguard group2.88M10.02%$450.94M
Avoro capital advisors2.66M9.20%$365.64M
State street1.33M4.71%$244.77M
Capital world investors942.25K3.26%$129.52M
Soleus capital management922.96K3.19%$126.87M
Braidwell lp727.81K2.52%$100.04M
Frazier life sciences management688.46K2.38%$94.64M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group663.47K9.71%$91.20M
Soleus capital management922.96K8.40%$126.87M
Avoro capital advisors2.66M6.40%$365.64M
S squared109.22K6.33%$15.01M
Frazier life sciences management688.46K3.78%$94.64M
Braidwell lp727.81K3.42%$100.04M
Palisades investment partners40.20K2.42%$5.53M
Decheng capital66.00K2.29%$9.07M
Evolutionary tree capital management12.30K1.79%$1.69M
Logos global management lp100.00K1.52%$13.75M

Top Buyers

HolderShares% AssetsChange
Blackrock3.95M0.02%2.14M
Soleus capital management922.96K8.40%481.20K
State street1.33M0.01%388.33K
Braidwell lp727.81K3.42%327.07K
Norges bank219.53K0.00%219.53K

Top Sellers

HolderShares% AssetsChange
Ikarian capital---375.00K
T. rowe price investment management---185.55K
Baker bros. advisors lp---169.93K
Lord, abbett---151.22K
1832 asset management---136.00K

New Positions

HolderShares% AssetsChangeValue
Norges bank219.53K0.00%219.53K$34.39M
Readystate asset management lp147.98K0.62%147.98K$20.34M
Logos global management lp100.00K1.52%100.00K$13.75M
William blair investment management91.10K0.03%91.10K$12.52M
Eagle asset management76.26K0.07%76.26K$13.90M

Sold Out

HolderChange
Assetmark-1.00
Tfc financial management-1.00
Mendota financial group-2.00
Bokf, na-2.00
Riverview trust-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025280-10.26%27,626,5581.12%951.06%140-8.50%94-16.07%
Mar 31, 20253109.54%27,310,084-1.64%941.01%15213.43%11112.12%
Dec 31, 2024175-41.28%17,639,222-37.00%610.65%85-45.51%63-31.52%
Sep 30, 202429716.47%27,997,874-1.68%970.98%156-9231.43%
Jun 30, 2024253-28,459,26112.90%1001.17%15518.32%69-19.77%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Select Biotechnology1.86M6.42%-
iShares Core S&P Small-Cap ETF1.52M5.25%220.00
Fidelity Growth Compy Commingled Pl S963.66K3.33%964.00
Fidelity Growth Compy Commingled Pl O915.43K3.19%-
American Funds SMALLCAP World A886.71K3.07%-
Vanguard US Total Market Shares ETF824.72K2.86%704.00
Vanguard Total Stock Mkt Idx Inv818.09K2.83%-17.16K
Fidelity Growth Company Fund707.20K2.45%-
Vanguard Small Cap Index631.98K2.18%-3.60K
iShares Russell 2000 ETF583.39K2.02%-11.13K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 15, 2025Krishnan Suma President, R&DSell$329.09K
Jul 15, 2025Krishnan Suma President, R&DSell$136.61K
Jul 16, 2025Krishnan Suma President, R&DSell$208.35K
Jul 14, 2025Krishnan Suma President, R&DSell$2.00M
Jul 14, 2025Krishnan Suma President, R&DSell$2.01M

Insider Transactions Trends


DateBuySell
2025 Q3-30
2025 Q2--
2025 Q1-21
2024 Q4-34
2024 Q3-30

KRYS Ownership FAQ


Who Owns Krystal Biotech?

Krystal Biotech shareholders are primarily institutional investors at 95.56%, followed by 11.86% insiders and -7.42% retail investors. The average institutional ownership in Krystal Biotech's industry, Biotech Stocks , is 306.59%, which Krystal Biotech falls below.

Who owns the most shares of Krystal Biotech?

Krystal Biotech’s largest shareholders are Fmr (4.31M shares, 15.02%), Blackrock (3.95M shares, 13.95%), and Blackrock funding, inc. /de (3.85M shares, 13.30%). Together, they hold 42.28% of Krystal Biotech’s total shares outstanding.

Does Blackrock own Krystal Biotech?

Yes, BlackRock owns 13.95% of Krystal Biotech, totaling 3.95M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 724.98M$. In the last quarter, BlackRock increased its holdings by 2.14M shares, a 118.67% change.

Who is Krystal Biotech’s biggest shareholder by percentage of total assets invested?

Redmile group is Krystal Biotech’s biggest shareholder by percentage of total assets invested, with 9.71% of its assets in 663.47K Krystal Biotech shares, valued at 91.2M$.

Who is the top mutual fund holder of Krystal Biotech shares?

Fidelity Select Biotechnology is the top mutual fund holder of Krystal Biotech shares, with 6.42% of its total shares outstanding invested in 1.86M Krystal Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools